{
    "clinical_study": {
        "@rank": "104042", 
        "brief_summary": {
            "textblock": "the purpose of the study is to extend the use of Rasagelin Mesylate 1mg per day by  subjects\n      who participated in the Adagio TVP 1012/501 according to form 4a for additional three years."
        }, 
        "brief_title": "Continuation Treatment Protocol for Patients Who Participated in the Adagio TVP 1012/501 Clinical Trial", 
        "condition": "Parkinson Disease", 
        "condition_browse": {
            "mesh_term": "Parkinson Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  subjects who are willing to contiue this treatment.\n\n          -  subjects who took part in the TVP 1012/501 clinical trail.\n\n        Exclusion Criteria:\n\n          -  subjects who didn't take part in the TVP 1012/501 clinical trail."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "30 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "subjects who took part in the TVP 1012/501 clinical trial and willing to contiue receiving\n        Rasgiline Mesylate."
            }
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01709461", 
            "org_study_id": "RD  06 - 12"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 16, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Petach Tiqva", 
                    "country": "Israel", 
                    "state": "Hamerkaz", 
                    "zip": "49100"
                }, 
                "name": "Rabin Medical Center Beilinson Campus"
            }, 
            "investigator": {
                "last_name": "Ruth Djaldetti, Professor", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_groups": "1", 
        "official_title": "Continue Providing Care for Patient Who Participated in the Adagio TVP 1012/501 Clinical Trial", 
        "overall_contact": {
            "email": "ruthdjal@clalit.org.il", 
            "last_name": "Ruth Djaldetti, Professor", 
            "phone": "972-9378218/9"
        }, 
        "overall_contact_backup": {
            "email": "yar@clalit.org.il", 
            "last_name": "Yaniv roditi, Msc", 
            "phone": "972-39236843"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israeli: Health Ministry Pharmaceutical Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01709461"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Rabin Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rabin Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "June 2012"
    }
}